Pearl IRB becomes a SMART IRB participating institution
INDIANAPOLIS, INDIANA – August 21, 2017 — Pearl IRB is pleased to announce that we have joined SMART IRB, a platform to ease common challenges and burdens associated with initiating multisite research. SMART IRB is a collaborative initiative supported by the National Center for Advancing Translational Sciences (NCATS) and led by Harvard Catalyst, University of Wisconsin-Madison ICTR, and Dartmouth Synergy.
Through a flexible master IRB reliance agreement, standard operating procedures, and complementary tools and resources, SMART IRB supports and encourages collaboration and harmonization across a national consortium of institutions. Together with SMART IRB, we will shape the future of multisite research across the nation, creating a network that will foster and enhance collaboration.
Pearl IRB strives to deliver superior independent review board services to improve the clinical research process thereby delivering new therapeutics and diagnostics to patients sooner.
The goal of SMART IRB is to streamline the IRB review process in multisite research, help investigators obtain trial results faster and, ultimately, advance the development of new diagnostics, treatments, and preventative measures for patients, while maintaining strong human research protections, oversight, and regulatory compliance.
Under the SMART IRB Agreement, investigators conducting multisite research may request that participating institutions rely on the review of a single IRB, and institutions may elect to do so on a study-by-study basis.
A full list of participating institutions and more information may be found at www.smartirb.org.
For information about how you can leverage SMART IRB for your research, please contact us today.
About Pearl IRB
Pearl IRB is an independent institutional review board, fully accredited by the Association for the Accreditation of Human Research Protection Program Inc. (AAHRPP). Pearl IRB manages the local and central IRB needs for large and small institutions, principal investigators, CROs, and sponsors. Our vision is to improve the clinical research process which will lead to delivering therapeutics and diagnostics to patients sooner. Whether the research is a small single site project or a complex multi-center study, we can help.
Pearl IRB is part of Pearl Pathways, a comprehensive life science product development services company. Pearl Pathways supports biopharmaceutical, medical device, and diagnostic companies as well as life science service providers with clinical, regulatory, and quality compliance needs. Whether you are small startup, still in the pre-commercialization stage, or a large multinational company with several products on the market, Pearl Pathways is equipped to serve you. Learn more at www.pearlpathways.com.
To learn more, please visit us at www.pearlirb.com, call us at (317) 899-9341, or email email@example.com. Pearl IRB is located in Indianapolis, Indiana, and is AAHRPP accredited and a WBENC certified woman owned business. For media inquiries, contact firstname.lastname@example.org.
FOR IMMEDIATE RELEASE